(Q55262047)

29 June 2018

title

Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients. (English)

1 reference

29 June 2018

author name string

C Kihara

1

1 reference

29 June 2018

T Seki

2

1 reference

29 June 2018

Y Furukawa

3

1 reference

29 June 2018

H Yamana

4

1 reference

29 June 2018

Y Kimura

5

1 reference

29 June 2018

P van Schaardenburgh

6

1 reference

29 June 2018

K Hirata

7

1 reference

29 June 2018

Y Nakamura

8

1 reference

29 June 2018

publication date

1 February 2000

1 reference

29 June 2018

number of pages

9

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

29 June 2018

volume

91

1 reference

29 June 2018

page(s)

190-198

1 reference

29 June 2018

issue

2

1 reference

29 June 2018

p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

p53, the cellular gatekeeper for growth and division

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Specific DNA binding by different classes of human p53 mutants

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Predicting response to cancer chemotherapy: the role of p53.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926332

Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung

13 August 2018

1 reference

12 December 2020

p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas

1 reference

12 December 2020

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

12 December 2020

Prognostic significance of the p53 mutation in esophageal cancer

1 reference

12 December 2020

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

1 reference

12 December 2020

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies

1 reference

12 December 2020

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

12 December 2020

TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival

1 reference

12 December 2020

p53 point mutation and survival in colorectal cancer patients

1 reference

12 December 2020

10.1111/J.1349-7006.2000.TB00931.X

Identifiers

DOI

1 reference

29 June 2018

PMCID

5926332

1 reference

29 June 2018

PubMed ID

10761706

1 reference

29 June 2018